Pathogenesis of cognitive impairment in multiple sclerosis

Research output: Contribution to journalArticle

Abstract

Around a half of multiple sclerosis (MS) patients suffer from cognitive impairment such as attention deficit. A similar impairment is already observable in one third of patients with clinical isolated syndrome, suggesting that the symptom cannot be solely explained by the accumulation of demyelinated lesions. Recently, several studies indicated that demyelination and atrophy in specific regions of the brain are related to the cognitive impairment, although those patients with brain and cognitive reserves are resistant to the development of such symptom. Aging, male sex and smoking increases whereas certain disease-modifying therapy decreases the risk of cognitive impairment in MS. Together, the development of cognitive impairment in MS appears to be determined by the balance between specific aggravating and protective factors.

Original languageEnglish
Pages (from-to)1063-1065
Number of pages3
JournalClinical Neurology
Volume54
Issue number12
Publication statusPublished - 2014

Fingerprint

Multiple Sclerosis
Cognitive Reserve
Demyelinating Diseases
Atrophy
Smoking
Cognitive Dysfunction
Brain
Therapeutics

Keywords

  • Brain atrophy
  • Cognitive impairment
  • Demyelination
  • Multiple sclerosis

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

Pathogenesis of cognitive impairment in multiple sclerosis. / Nakahara, Jin.

In: Clinical Neurology, Vol. 54, No. 12, 2014, p. 1063-1065.

Research output: Contribution to journalArticle

@article{12bad587387d487199cb023ca6904c65,
title = "Pathogenesis of cognitive impairment in multiple sclerosis",
abstract = "Around a half of multiple sclerosis (MS) patients suffer from cognitive impairment such as attention deficit. A similar impairment is already observable in one third of patients with clinical isolated syndrome, suggesting that the symptom cannot be solely explained by the accumulation of demyelinated lesions. Recently, several studies indicated that demyelination and atrophy in specific regions of the brain are related to the cognitive impairment, although those patients with brain and cognitive reserves are resistant to the development of such symptom. Aging, male sex and smoking increases whereas certain disease-modifying therapy decreases the risk of cognitive impairment in MS. Together, the development of cognitive impairment in MS appears to be determined by the balance between specific aggravating and protective factors.",
keywords = "Brain atrophy, Cognitive impairment, Demyelination, Multiple sclerosis",
author = "Jin Nakahara",
year = "2014",
language = "English",
volume = "54",
pages = "1063--1065",
journal = "Clinical Neurology",
issn = "0009-918X",
publisher = "Societas Neurologica Japonica",
number = "12",

}

TY - JOUR

T1 - Pathogenesis of cognitive impairment in multiple sclerosis

AU - Nakahara, Jin

PY - 2014

Y1 - 2014

N2 - Around a half of multiple sclerosis (MS) patients suffer from cognitive impairment such as attention deficit. A similar impairment is already observable in one third of patients with clinical isolated syndrome, suggesting that the symptom cannot be solely explained by the accumulation of demyelinated lesions. Recently, several studies indicated that demyelination and atrophy in specific regions of the brain are related to the cognitive impairment, although those patients with brain and cognitive reserves are resistant to the development of such symptom. Aging, male sex and smoking increases whereas certain disease-modifying therapy decreases the risk of cognitive impairment in MS. Together, the development of cognitive impairment in MS appears to be determined by the balance between specific aggravating and protective factors.

AB - Around a half of multiple sclerosis (MS) patients suffer from cognitive impairment such as attention deficit. A similar impairment is already observable in one third of patients with clinical isolated syndrome, suggesting that the symptom cannot be solely explained by the accumulation of demyelinated lesions. Recently, several studies indicated that demyelination and atrophy in specific regions of the brain are related to the cognitive impairment, although those patients with brain and cognitive reserves are resistant to the development of such symptom. Aging, male sex and smoking increases whereas certain disease-modifying therapy decreases the risk of cognitive impairment in MS. Together, the development of cognitive impairment in MS appears to be determined by the balance between specific aggravating and protective factors.

KW - Brain atrophy

KW - Cognitive impairment

KW - Demyelination

KW - Multiple sclerosis

UR - http://www.scopus.com/inward/record.url?scp=84919714553&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84919714553&partnerID=8YFLogxK

M3 - Article

VL - 54

SP - 1063

EP - 1065

JO - Clinical Neurology

JF - Clinical Neurology

SN - 0009-918X

IS - 12

ER -